Centre for Research Excellence Polycystic Ovary Syndrome (CREPCOS)
A compelling case for a Centre for Research Excellence (CRE) in the evaluation, management and health care needs of Polycystic Ovary Syndrome (PCOS) and related health implications was identified and presented to the National Health and Medical Research Council (NHMRC). It was funded in 2014 for the duration of five years.
The decision to establish the CRE was influenced by:
- evidence defining the need for urgent action and the opportunity for impact
- unprecedented evidence synthesis including NHMRC approved guidelines yielding highly focused research and translation priorities
- five years of extensive stakeholder engagement through the PCOS Australian Alliance
- access to an internationally recognised team of collaborative research and translation experts and stakeholders
The CRE is uniquely positioned to build on the foundations of why, when, what and who with, addressing vital knowledge gaps to improve diagnosis, capture vital prevention opportunities, optimise management and improve quality of life. It will promote expertise and versatility in the next generation of research leaders, enhancing Australia’s global reputation in research excellence, translation, and training.